» Articles » PMID: 24440910

P63 is a Prosurvival Factor in the Adult Mammary Gland During Post-lactational Involution, Affecting PI-MECs and ErbB2 Tumorigenesis

Overview
Specialty Cell Biology
Date 2014 Jan 21
PMID 24440910
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

In embryogenesis, p63 is essential to develop mammary glands. In the adult mammary gland, p63 is highly expressed in the basal cell layer that comprises myoepithelial and interspersed stem/progenitor cells, and has limited expression in luminal epithelial cells. In adult skin, p63 has a crucial role in the maintenance of epithelial stem cells. However, it is unclear whether p63 also has an equivalent role as a stem/progenitor cell factor in adult mammary epithelium. We show that p63 is essential in vivo for the survival and maintenance of parity-identified mammary epithelial cells (PI-MECs), a pregnancy-induced heterogeneous population that survives post-lactational involution and contain multipotent progenitors that give rise to alveoli and ducts in subsequent pregnancies. p63+/- glands are normal in virgin, pregnant and lactating states. Importantly, however, during the apoptotic phase of post-lactational involution p63+/- glands show a threefold increase in epithelial cell death, concomitant with increased activation of the oncostatin M/Stat3 and p53 pro-apoptotic pathways, which are responsible for this phase. Thus, p63 is a physiologic antagonist of these pathways specifically in this regressive stage. After the restructuring phase when involution is complete, mammary glands of p63+/- mice again exhibit normal epithelial architecture by conventional histology. However, using Rosa(LSL-LacZ);WAP-Cre transgenics (LSL-LacZ, lox-stop-lox β-galactosidase), a genetic in vivo labeling system for PI-MECs, we find that p63+/- glands have a 30% reduction in the number of PI-MEC progenitors and their derivatives. Importantly, PI-MECs are also cellular targets of pregnancy-promoted ErbB2 tumorigenesis. Consistent with their PI-MEC pool reduction, one-time pregnant p63+/- ErbB2 mice are partially protected from breast tumorigenesis, exhibiting extended tumor-free and overall survival, and reduced tumor multiplicity compared with their p63+/+ ErbB2 littermates. Conversely, in virgin ErbB2 mice p63 heterozygosity provides no survival advantage. In sum, our data establish that p63 is an important survival factor for pregnancy-identified PI-MEC progenitors in breast tissue in vivo.

Citing Articles

p63: A Master Regulator at the Crossroads Between Development, Senescence, Aging, and Cancer.

Sadu Murari L, Kunkel S, Shetty A, Bents A, Bhandary A, Rivera-Mulia J Cells. 2025; 14(1.

PMID: 39791744 PMC: 11719615. DOI: 10.3390/cells14010043.


Crosstalk between paralogs and isoforms influences p63-dependent regulatory element activity.

Baniulyte G, McCann A, Woodstock D, Sammons M Nucleic Acids Res. 2024; 52(22):13812-13831.

PMID: 39565223 PMC: 11662943. DOI: 10.1093/nar/gkae1143.


Tristetraprolin promotes survival of mammary progenitor cells by restraining TNFα levels.

Stedile M, Lara Montero A, Garcia Sola M, Goddio M, Beckerman I, Bogni E Front Cell Dev Biol. 2024; 11:1265475.

PMID: 38274271 PMC: 10808302. DOI: 10.3389/fcell.2023.1265475.


p63: a crucial player in epithelial stemness regulation.

Li Y, Giovannini S, Wang T, Fang J, Li P, Shao C Oncogene. 2023; 42(46):3371-3384.

PMID: 37848625 PMC: 10638092. DOI: 10.1038/s41388-023-02859-4.


NOTCH and AKT Signalling Interact to Drive Mammary Tumour Heterogeneity.

Ordonez L, Tornillo G, Kendrick H, Hay T, Smalley M Cancers (Basel). 2023; 15(17).

PMID: 37686600 PMC: 10486941. DOI: 10.3390/cancers15174324.


References
1.
Suliman Y, Opitz O, Avadhani A, Burns T, El-Deiry W, Wong D . p63 expression is associated with p53 loss in oral-esophageal epithelia of p53-deficient mice. Cancer Res. 2001; 61(17):6467-73. View

2.
Holembowski L, Schulz R, Talos F, Scheel A, Wolff S, Dobbelstein M . While p73 is essential, p63 is completely dispensable for the development of the central nervous system. Cell Cycle. 2011; 10(4):680-9. PMC: 3174004. DOI: 10.4161/cc.10.4.14859. View

3.
Muller W, Sinn E, Pattengale P, Wallace R, Leder P . Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene. Cell. 1988; 54(1):105-15. DOI: 10.1016/0092-8674(88)90184-5. View

4.
Wang X, Mori I, Tang W, Nakamura M, Nakamura Y, Sato M . p63 expression in normal, hyperplastic and malignant breast tissues. Breast Cancer. 2002; 9(3):216-9. DOI: 10.1007/BF02967592. View

5.
Nylander K, Vojtesek B, Nenutil R, Lindgren B, Roos G, Zhanxiang W . Differential expression of p63 isoforms in normal tissues and neoplastic cells. J Pathol. 2002; 198(4):417-27. DOI: 10.1002/path.1231. View